Higher level of Dickkopf-1 is associated with low bone mineral density and higher prevalence of vertebral fractures in patients with ankylosing spondylitis

M Rossini, O Viapiana, L Idolazzi, F Ghellere… - Calcified tissue …, 2016 - Springer
Patients with ankylosing spondylitis (AS) have an increased risk of bone loss and vertebral
fractures. In this study, we explored the hypothesis that the excess bone loss and vertebral …

The effect of postmenopausal osteoporosis on subchondral bone pathology in a rat model of knee osteoarthritis

H Wada, K Aso, M Izumi, M Ikeuchi - Scientific Reports, 2023 - nature.com
This study aimed to investigate the additional effect of ovariectomy-induced osteoporosis
(OP) on the pathology of knee osteoarthritis (OA) in a rat meniscectomized model …

Bone changes in early rheumatoid arthritis

MJ Green, AA Deodhar - Best Practice & Research Clinical Rheumatology, 2001 - Elsevier
Bone disease in rheumatoid arthritis affects the peri-articular and axial skeleton and is a
major cause of disability. Recent studies have shown that pro-inflammatory cytokines …

Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis

S Samara, Z Dailiana, C Chassanidis… - Experimental and …, 2014 - Elsevier
Introduction Femoral head avascular necrosis (AVN) is a recalcitrant disease of the hip that
leads to joint destruction. Osteoprotegerin (OPG), Receptor Activator of Nuclear Factor …

The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients

XF Wang, YK Zhang, ZS Yu… - Molecular medicine …, 2013 - spandidos-publications.com
Intertrochanteric fractures occur most commonly in elderly patients. Osteoblasts and
osteoclasts have been reported to be regulated by the receptor activator of NF-κB ligand …

The role of RANK ligand/osteoprotegerin in rheumatoid arthritis

P Geusens - Therapeutic advances in musculoskeletal …, 2012 - journals.sagepub.com
In the complex system of bone remodeling, the receptor activator of nuclear factor κB ligand
(RANKL)/osteoprotegerin (OPG) pathway is the coupling factor between bone formation and …

Involvement of interleukin-6 and prostaglandin E2 in periarticular osteoporosis of postmenopausal women with rheumatoid arthritis

T Sugiyama - Journal of bone and mineral metabolism, 2001 - Springer
In experimental arthritis, blocking of the receptor activator of nuclear factor κB ligand
(RANKL) by osteo-protegerin (OPG) treatment prevents bone loss but not inflammation …

Markers of bone formation and resorption identify subgroups of patients with clinical knee osteoarthritis who have reduced rates of cartilage loss

PA Berry, RA Maciewicz, FM Cicuttini… - The Journal of …, 2010 - jrheum.org
Objective. To determine whether serum markers of bone formation and resorption, used
individually or in combination, can be used to identify subgroups who lose cartilage volume …

Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis

L Senolt, H Hulejova, O Krystufkova… - Annals of the …, 2012 - ard.bmj.com
Objective Dickkopf-1 (DKK-1) is an inhibitor of osteoblastogenesis, and its lower levels are
linked to new bone formation. The aim of this study was therefore to explore serum levels of …

[引用][C] The role of osteoprotegerin and receptor activator of nuclear factor κB ligand in the pathogenesis and treatment of rheumatoid arthritis

LC Hofbauer, AE Heufelder - Arthritis & Rheumatism: Official …, 2001 - Wiley Online Library
The skeletal complications of rheumatoid arthritis (RA) include focal bone erosions and
juxtaarticular osteopenia at sites of active inflammation, as well as systemic osteopenia …